Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Financial Intranet Inc. (OTC:BB:FNTN) -- Ignore unavailable to you. Want to Upgrade?

To: dharampal luthra who wrote (2064)	6/3/1998 7:50:00 AM
From: Ariella	Respond to of 2897

Hi -- add my 30,000 FNTN to your count. I've posted here before and am patiently waiting for the climb into the black for earnings that management predicted this year. You can also find me on the PARS board. PARS is an undiscovered Israeli pharmaceutical house that has its first two drugs coming to market already in cooperation with Bausch & Lomb (a $40 million/yr probable revenue stream just for PARS), a big-potential brain trauma drug going into Phase III trials this summer, and the stock sells for $2.75/share. Who says there are not opportunities for small investors on Wall Street? Go FNTN, go. Ariella